Market News & Trends
NanoSight Acquired by Malvern Instruments
NanoSight Ltd recently announced it has been acquired by Malvern Instruments Ltd with the acquisition being completed on September 27. NanoSight has developed and commercialized…
Catalent Announces Expansion to Improve Bioavailability
Catalent Pharma Solutions recently announced several advancements and expansion of its OptiMelt Hot Melt Extrusion (HME) capabilities in Somerset, NJ. Catalent’s OptiMelt technology is designed…
British Pharmaceutical Market to Reach $31.7 Billion
A growing disease burden, universal coverage, and good access to healthcare facilities are boosting the UK healthcare market; but increasing use of generics and government…
ProStrakan Launches First Transdermal CINV Drug; 3M DDS to Manufacture
The European Medicines Agency (EMA) has recently granted approval for ProStrakan Group plc to market SANCUSO (Granisetron Transdermal System) in the European Union (EU), with…
JHP Pharmaceuticals Enters Ophthalmic Manufacturing Agreement
JHP Pharmaceuticals recently announced it has entered into a manufacturing agreement with an undisclosed pharmaceutical company, which has developed proprietary products that provide sustained and…
Mystic Pharmaceuticals Receives Multiple Patent Allowance on Platform Technologies
Mystic Pharmaceuticals, Inc. recently announced it has received two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform (serial…
Veritas Bio’s RNA Delivery Patent Allowed
Veritas Bio, LLC, recently announce that the European Patent Office (EPO) has granted a patent to Veritas for European Patent Application No. 07 873 598.2…
Supernus & Catalent Enter Supply Agreement
Catalent Pharma Solutions and Supernus Pharmaceuticals recently announced they have entered into an agreement in which Catalent is the supplier of Trokendi XR extended-release capsules…
Capsugel Expands Global Manufacturing for Finished Dosage Forms
Capsugel’s Dosage Form Solutions (DFS) business unit recently unveiled extensive upgrades and expansions to three of its manufacturing facilities in the US and Europe, deepening…
Chiesi Farmaceutici SpA & Cornerstone Therapeutics Announce Merger Transaction
Chiesi Farmaceutici S.p.A. and Cornerstone Therapeutics Inc. recently announced that the special committee of the Cornerstone Board of Directors, as well as the boards of…
Amicus Therapeutics & Biogen Idec to Collaborate
Amicus Therapeutics recently announced it has entered a collaboration with Biogen Idec (BIIB) to discover, develop, and commercialize novel small molecules for the treatment of…
Roche & Inovio Enter $422.5-Million Licensing Deal
Roche and Inovio Pharmaceuticals, Inc. recently announced they have entered into an exclusive worldwide license agreement to research, develop and commercialize Inovio's highly optimized, multi-antigen…
AstraZeneca Pays $50 Million Up-Front for Cancer Drug
Merck and AstraZeneca recently announced a worldwide licensing agreement for Merck’s oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in…
Unilife Signs Long-Term Supply Contract With Sanofi
Unilife Corporation recently announced the signing of a long-term supply contract with Sanofi. Unilife has agreed to supply Sanofi with the Unifill Finesse, a customized…
EPO Grants Hovione New Inhaler Patent
Hovione recently announced the European Patent Office has granted a patent for Hovione’s XCaps, a dry powder inhaler (DPI). XCaps addresses a pulmonary inhalation market…
Catalent Appoints Appoints New Asia Pacific President
Catalent Pharma Solutions recently announced it has named David Heyens in the new role of President of Catalent Asia Pacific. Reporting directly to Catalent’s President…
FDA Approves Third Drug in BD Simplist Prefilled Injectable Line of Products
BD Rx Inc., a wholly owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company), recently announced the US FDA has approved…
TesoRx & CoreRx Announce Lucrative Joint Venture
TesoRx Pharma, LLC and CoreRx, Inc. recently announced a manufacturing joint venture to produce TSX-002, a first-in-class oral testosterone drug targeting the $2.5-billion low testosterone…
Rani Therapeutics Secures Funding Led by Google Ventures
Rani Therapeutics recently announced it has closed its Series B round of funding, led by Google Ventures. InCube Ventures, a life sciences venture fund that…
Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
Cost benefits and pharmaceutical companies’ desire to focus on their core competencies has created an increasing need for outsourcing and spurred the global pharmaceutical contract…
